These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12743427)

  • 21. Prognostic nomogram incorporating inflammatory cytokines for overall survival in patients with aggressive non-Hodgkin's lymphoma.
    Zhong H; Chen J; Cheng S; Chen S; Shen R; Shi Q; Xu P; Huang H; Zhang M; Wang L; Wu D; Zhao W
    EBioMedicine; 2019 Mar; 41():167-174. PubMed ID: 30827933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High Serum Soluble CD27 Level Correlates with Poor Performance Status and Reduced Survival in Patients with Advanced Lung Cancer.
    Kashima J; Okuma Y; Hosomi Y; Hishima T
    Oncology; 2019; 97(6):365-372. PubMed ID: 31533124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum thymidine kinase activity: an alternative to histologic markers of cellular proliferation in canine lymphoma.
    Madewell BR
    J Vet Intern Med; 2004; 18(5):595-6. PubMed ID: 15515571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma.
    Broyde A; Boycov O; Strenov Y; Okon E; Shpilberg O; Bairey O
    Am J Hematol; 2009 Jun; 84(6):338-43. PubMed ID: 19384938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating levels of TNF alpha and TNF receptor superfamily members in lymphoid neoplasia.
    Metkar SS; Naresh KN; Manna PP; Srinivas V; Advani SH; Nadkarni JJ
    Am J Hematol; 2000 Oct; 65(2):105-10. PubMed ID: 10996826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated serum levels of soluble ICAM-1 in non-Hodgkin's lymphomas correlate with tumour burden, disease activity and other prognostic markers.
    Christiansen I; Gidlof C; Kälkner K M; Hagberg H; Bennmarker H; Tötterman T
    Br J Haematol; 1996 Mar; 92(3):639-46. PubMed ID: 8616029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An improved prognostic parameter for non-Hodgkin's lymphoma based on the combination of three serum tumor markers.
    Gui W; Wang T; Wang J; Wang L; He J; Yang B; Zhao Z; Zhang H; Zhang Q
    Int J Biol Markers; 2008; 23(4):207-13. PubMed ID: 19199267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic utility of CSF soluble CD27 for primary central nervous system lymphoma in immunocompetent patients.
    Murase S; Saio M; Andoh H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Takami T
    Neurol Res; 2000 Jul; 22(5):434-42. PubMed ID: 10935213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thymidine kinase levels correlate with prognosis in aggressive lymphoma and can discriminate patients with a clinical suspicion of indolent to aggressive transformation.
    Gatt ME; Goldschmidt N; Kalichman I; Friedman M; Arronson AC; Barak V
    Anticancer Res; 2015 May; 35(5):3019-26. PubMed ID: 25964590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic relevance of serum-markers in relation to histopathology, stage and initial symptoms in advanced low-grade non-Hodgkin lymphomas.
    Martinsson U; Glimelius B; Hagberg H; Sundström C
    Eur J Haematol; 1988 Apr; 40(4):289-98. PubMed ID: 3366218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation and prognostic value of serum soluble ICAM-1, beta-2 microglobulin, and IL-2alphaR levels in non-Hodgkin's lymphoma.
    Pérez-Encinas M; Quintas A; Bendaña A; Rabuñal MJ; Bello JL
    Leuk Lymphoma; 1999 May; 33(5-6):551-8. PubMed ID: 10342582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ki-67 proliferative index in non-Hodgkin's lymphoma and its clinical significance].
    Li J; Hu R; Liao AJ; Shi HY; Yan W; Liu ZG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):935-9. PubMed ID: 21867618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated serum levels of soluble CD44 variant 6 are correlated with shorter survival in aggressive non-Hodgkin's lymphoma.
    Sasaki K; Niitsu N
    Eur J Haematol; 2000 Sep; 65(3):195-202. PubMed ID: 11007056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing DcR3 expression in relation to survivin and other prognostic factors in B cell non-Hodgkin's lymphoma.
    Bedewy AM; Elgammal MM; Bedewy MM; El-Maghraby SM
    Ann Hematol; 2013 Oct; 92(10):1359-67. PubMed ID: 23652586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of circulating CD44 in non-Hodgkin's lymphoma.
    Ristamäki R; Joensuu H; Hagberg H; Kalkner KM; Jalkanen S
    Int J Cancer; 1998 Jun; 79(3):221-5. PubMed ID: 9645341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus-related systemic non-Hodgkin lymphoma.
    Rossi G; Donisi A; Casari S; Re A; Cadeo G; Carosi G
    Cancer; 1999 Dec; 86(11):2391-7. PubMed ID: 10590382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy.
    Nagato T; Komatsuda H; Hayashi R; Takahara M; Kishibe K; Yasuda S; Yajima Y; Kosaka A; Ohkuri T; Oikawa K; Harabuchi S; Kono M; Yamaki H; Wakisaka R; Hirata-Nozaki Y; Ohara K; Kumai T; Katada A; Hayashi T; Harabuchi Y; Kobayashi H
    Cancer Immunol Immunother; 2023 Jul; 72(7):2087-2098. PubMed ID: 36811663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-Hodgkin lymphoma in elderly patients: experience at Taipei Veterans General Hospital.
    Bai LY; Yang MH; Chiou TJ; Liu JH; Yen CC; Wang WS; Hsiao LT; Chao TC; Chen PM
    Cancer; 2003 Sep; 98(6):1188-95. PubMed ID: 12973842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of serum thymidine kinase in non-Hodgkin lymphoma: relationship to other prognostic factors.
    Hallek M; Emmerich B; Strohmeyer S; Busch R; Reichle A; Senekowitsch R
    Klin Wochenschr; 1988 Aug; 66(16):718-23. PubMed ID: 3172680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Detection of soluble interleukin-2 receptor in the serum of patients with non-Hodgkin's lymphoma].
    Pérez Encinas M; Bello JL; Bendaña A; Rabuñal MJ; González S; Abuín I; Noya M; Cadarso C
    Med Clin (Barc); 1998 Jul; 111(5):161-7. PubMed ID: 9732831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.